| Date | Title | File |
|---|---|---|
|
Aug 04, 2020
|
Q2 2020 Financial and Corporate Update Presentation
|
|
|
May 05, 2020
|
Q1 2020 Financial and Corporate Update Presentation
|
|
|
Apr 06, 2020
|
Ruxolitinib Cream: Phase 3 Data in Atopic Dermatitis
|
|
|
Jan 13, 2020
|
J. P. Morgan 38th Annual Healthcare Conference Presentation
|
|
|
Sep 27, 2019
|
ESMO 2019: Pemigatinib Development Update
|
|
|
Jun 17, 2019
|
Ruxolitinib Cream: Phase 2 Data in Vitiligo
|
